Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously

Overview of attention for article published in Breast Cancer Research and Treatment, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,819 followers.

@RobClarkeLab

03 Dec 2019

Reply Repost Favourite

Publication | Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast #CancerStemCells and non-stem breast cancer cells simultaneously. https://t.co/12wkqLeuMW

03 Dec 2019

Reply Repost Favourite

New article: Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously. https://t.co/pHYYjkBoUI #breastcancer #oncology

01 Dec 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.